However, some PKD activators and substrates that play an important role in membrane trafficking have also been attributed tumor-promoting properties, particularly in breast cancer, implying that PDK-regulated membrane trafficking may contribute to breast cancer progression. This evidence concerns the gene PRKD1 and breast carcinoma.